BioSpace News Archive

The pharmacovigilance outsourcing market has been predicted to grow at a noticeable pace in the forthcoming years.

The pharmaceutical contract development market has been anticipated to expand at a noteworthy speed throughout the forecast period.

Genentech, a member of the Roche Group, announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2022.

BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced a corporate restructuring plan to focus its resources and extend the cash runway.

Alithea Genomics, a fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with participation of Swiss-based private investors.

Upstream Peripheral Technologies announced that it has partnered with Red One Medical for the introduction of the GoBack® Crossing and Reentry Catheter to the VA Health System.

CareDx, Inc. announced that it has received CE marking for its AlloSeq HCT chimerism testing kit and AlloSeq HCT interpretation software for use in patients who have received hematopoietic cell transplantation.

Affimed N.V. announced that it will release first quarter 2022 results and corporate update on Wednesday, June 1, 2022.

Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced an oral podium presentation and a poster presentation at the American Society of Clinical Psychopharmacology Annual Meeting (ASCP 2022), being held May 31 – June 3, 2022, in Scottsdale, Ariz.

United Digestive, a physician practice management company focused on gastroenterology, announced its expansion of therapeutic gastroenterology services in the coastal Georgia region with the addition of new provider, Dr. Daniel K. Mullady.